About
About journalGoals and objectivesEditorial councilContacts
ArchiveSubscription
To Authors
Copyright agreementProcedure for reviewingRequirements for publicationsSend articlePrivacy DeclarationConflicts of Interest DeclarationCriteria for authorship
Ethical Standards
ISSN 2073–4034
eISSN 2414–9128
About
About journalGoals and objectivesEditorial councilContacts
ArchiveSubscription
To Authors
Copyright agreementProcedure for reviewingRequirements for publicationsSend articlePrivacy DeclarationConflicts of Interest DeclarationCriteria for authorship
Ethical Standards
Logout
Year
2025202420232022202120202019201820172015201420132012201120102009200820072006200520042003200220012000
Edition number
№20 (333)№s5-16№19 (332)№18 (331)№17 (330)№16 (329)№s4-16№s3-16№15 (328)№14 (327)№13 (326)№12 (325)№11 (324)№10 (323)№9 (322)№8 (321)№7 (320)№6 (319)№4 (317)№3 (316)№s2-16№2 (315)№s1-16№1 (314)

№5 (318) / 2016

A.S. Ametov (1), N.A. Chernikova (1), T.Yu. Demidova (1), P.K. Nazhmutdinova (2)
GLYCEMIC VARIABILITY AS A THERAPEUTIC TARGET IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
8-13
L.A. Ruyatkina (1), D.S. Ruyatkin (1), S.A. Zemlyanukhina (2)
DIABETIC ANGIOPATHY «PAINFUL» POINTS: FOCUS ON HYPERTRIGLYCERIDEMIA AND FENOFIBRATE POTENTIAL
14-21
A.V. Pashentseva, A.F. Verbovoy, O.V. Kosareva, L.A. Sharonova
MODERN POSSIBILITIES OF OSTEOPOROSIS TREATMENT
22-29
V.A. Golovacheva, V.A. Parfenov
MODERN TACTICS OF MANAGEMENT OF PATIENTS WITH DIABETIC POLYNEUROPATHY
30-37
M.B. Antsiferov
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
38-44
D.V. Kurkin, E.V. Volotova, D.A. Bakulin, E.M. Lomkina, I.N. Tyurenkov
INCRETIN SYSTEM AS PROMISING PHARMACOLOGICAL TARGET FOR HYPOGLYCEMIC THERAPY
45-50
E.V. Biryukova
EMPAGLIFLOZIN: ENHANCEMENT OF POTENTIALS OF THE TREATMENT OF TYPE 2 DIABETES MELLITUS
51-61
O.L. Badalyan, A.A. Savenkov
PATHOGENETIC THERAPY OF DIABETIC POLYNEUROPATHY
62-65
O.M. Koteshkova, L.P. Molina
EFFICIENCY OF MULTICOMPONENT THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (CLINICAL CASE)
66-70
M.F. Kalashnikova, A.V. Zilov, D.R. Yazykova, N.V. Likhodey, V.V. Fadeev
POTENTIALS FOR THE IMPROVEMENT OF TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS USING HUMAN ULTRA-LONG INSULIN ANALOGUE DEGLUDEC IN OUTPATIENT SETTINGS
71-78
D.V. Stafeev, A.Yu. Kochish, S.N. Ivanov
EVALUATION OF THE EFFICACY OF THERAPY OF OSTEOPOROSIS IN PATIENTS WITH EXTRA-ARTICULAR FRACTURES OF THE PROXIMAL FEMUR
79-85
A.S. Adamchik, D.I. Panchenko
INCREASED THYROID-STIMULATING HORMONE LEVEL AS A MARKER OF PROGRESSION OF HEART FAILURE IN CARDIAC PATIENTS
86-88
A.V. Tolkushin
OVERVIEW OF PHARMACOECONOMIC STUDIES OF INSULIN PUMP THERAPY IN DIABETES MELLITUS
89-95
By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.